Israel Englander’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.27M Sell
151,900
-354,800
-70% -$9.52M ﹤0.01% 2955
2026
Q1
$10.5M Buy
506,700
+309,100
+156% +$7.3M ﹤0.01% 2122
2025
Q4
$6.42M Sell
197,600
-335,000
-63% -$14.3M ﹤0.01% 2733
2025
Q3
$30.2M Buy
532,600
+352,700
+196% +$18.1M 0.01% 1252
2025
Q2
$8.97M Buy
179,900
+53,800
+43% +$2.43M ﹤0.01% 2372
2025
Q1
$3.73M Sell
126,100
-141,800
-53% -$5.27M ﹤0.01% 3156
2024
Q4
$6.48M Buy
267,900
+105,900
+65% +$2.62M ﹤0.01% 2597
2024
Q3
$2.98M Buy
+162,000
New +$2.9M ﹤0.01% 3319

Other funds holding HIMS

Israel Englander's HIMS Position: Q2 2026 in Review

Israel Englander sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 169,672 shares — an estimated $4.55M sold.

Israel Englander first reported a position in HIMS in Q4 2019 and held it in 25 quarters. The position peaked at $39.8M in Q2 2024. 504 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Israel Englander reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 169,672 Hims & Hers Health shares in Q2 2026, an estimated $4.55M.
  • Israel Englander first reported a position in Hims & Hers Health in Q4 2019 and held it in 25 quarters.
  • Israel Englander's Hims & Hers Health position peaked at $39.8M in Q2 2024.
  • 504 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.